Shennon Biotechnologies
CA - San FranciscoBiotechnology
Focus: Shennon Biotechnologies is a San Francisco-based biotech company developing proprietary single-cell platform technology to design more effective immunotherapies. The company is early-stage and pre-revenue, focused on oncology and neurology indications.
Profile data last refreshed 3h ago · AI intelligence enriched 3w ago
Open Jobs
5
Should You Work at Shennon Biotechnologies?
AI assessmentEarly-stage immunotherapy platform play best suited for scientists seeking hands-on pipeline impact; financial stability and growth trajectory remain unproven.
Why Work Here
- Platform-driven approach offers exposure to translational immunotherapy development with potential applications across oncology and neurology
- Early-stage company provides opportunity for significant technical impact and ownership in a lean R&D-focused organization
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Shennon Biotechnologies(1)
Help build intelligence for Shennon Biotechnologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.